T-lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for T-lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma [Phase 3]
A Phase 3 trial evaluating levocarnitine for protecting the liver during chemotherapy in various B-cell acute lymphoblastic leukemia and rel…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia [Phase 2]
Phase 2 clinical trial update for venetoclax combined with IM2 in relapsed/refractory T lymphoblastic lymphoma/leukemia.
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma [Phase 2]
Phase 2 clinical study of anti-CD1a CAR-T for relapsed/refractory acute T-lymphoblastic leukemia and lymphoblastic lymphoma is ongoing with …
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients [Phase 3]
Phase 3 clinical trial evaluating decitabine with HAAG regimen for newly diagnosed T-ALL and related T-ALL/LBL conditions with myeloid marke…